Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(40.0%)
N/A
1(20.0%)
Phase 3
1(20.0%)
Early Phase 1
1(20.0%)
5Total
Phase 4(2)
N/A(1)
Phase 3(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)